Continuous low-dose cyclophosphamide (NSC-26271) therapy in advanced ovarian cancer

Eur J Cancer (1965). 1976 May;12(5):353-6. doi: 10.1016/0014-2964(76)90172-9.
No abstract available

MeSH terms

  • Adult
  • Aged
  • Castration
  • Cyclophosphamide / administration & dosage
  • Cyclophosphamide / adverse effects
  • Cyclophosphamide / therapeutic use*
  • Female
  • Follow-Up Studies
  • Humans
  • Leukopenia / chemically induced
  • Middle Aged
  • Ovarian Neoplasms / drug therapy*
  • Prognosis
  • Thrombocytopenia / chemically induced

Substances

  • Cyclophosphamide